Sacituzumab Govitecan in HR-positive HER2-negative metastatic breast cancer.

ABSTRACT:

SUBMITTER: Nardin S 

PROVIDER: S-EPMC10061446 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature